Publicacións nas que colabora con Clara Bueno Uroz (18)

2019

  1. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

    Haematologica, Vol. 104, Núm. 6, pp. 1189-1201

2017

  1. RUNX1c Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling

    Stem Cells, Vol. 35, Núm. 11, pp. 2253-2266

2015

  1. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells

    Molecular Therapy, Vol. 23, Núm. 1, pp. 158-170

  2. The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate

    Leukemia, Vol. 29, Núm. 8, pp. 1741-1753

2014

  1. HOXA9 promotes hematopoietic commitment of human embryonic stem cells

    Blood, Vol. 124, Núm. 20, pp. 3065-3075

  2. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells

    Leukemia, Vol. 28, Núm. 3, pp. 666-674

2013

  1. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs

    Blood, Vol. 121, Núm. 19, pp. 3867-3878

  2. The role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells

    Blood

2012

  1. A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification

    Cell Research, Vol. 22, Núm. 6, pp. 986-1002

  2. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγnull mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells

    Clinical Immunology

  3. Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation

    Tissue Engineering - Part C: Methods, Vol. 18, Núm. 5, pp. 387-396

  4. Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification

    Stem Cells and Development, Vol. 21, Núm. 9, pp. 1549-1558

  5. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors

    PLoS ONE, Vol. 7, Núm. 4

  6. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells

    Molecular Therapy

  7. Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors

    PLoS ONE, Vol. 7, Núm. 6

2011

  1. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease

    Stem Cells, Vol. 29, Núm. 2, pp. 251-262

2010

  1. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection

    Stem Cells

  2. Nodal/activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage

    Molecular Therapy, Vol. 18, Núm. 12, pp. 2173-2181